BioCentury
ARTICLE | Company News

Axxam and Sanofi to optimize CNS compounds

October 20, 2017 6:09 PM UTC

Axxam S.p.A. (Milan, Italy) said last month it partnered with Sanofi (Euronext:SAN; NYSE:SNY) to optimize lead small molecules, discovered by Axxam, in development to treat CNS diseases. Research will be performed at Sanofi and Axxam facilities. The pharma has an option to the programs...

BCIQ Company Profiles

Axxam S.p.A.

Sanofi